113 related articles for article (PubMed ID: 35727197)
1. MPZL1 upregulation promotes tumor metastasis and correlates with unfavorable prognosis in non-small cell lung cancer.
Feng J; Ouyang H; Wang J; Pan D; Sheng L; Xu C; Lin W; Hu D; Chang C; Jia D
Carcinogenesis; 2022 Nov; 43(10):919-929. PubMed ID: 35727197
[TBL] [Abstract][Full Text] [Related]
2. Amplification of MPZL1/PZR promotes tumor cell migration through Src-mediated phosphorylation of cortactin in hepatocellular carcinoma.
Jia D; Jing Y; Zhang Z; Liu L; Ding J; Zhao F; Ge C; Wang Q; Chen T; Yao M; Li J; Gu J; He X
Cell Res; 2014 Feb; 24(2):204-17. PubMed ID: 24296779
[TBL] [Abstract][Full Text] [Related]
3. MPZL1 promotes tumor cell proliferation and migration via activation of Src kinase in ovarian cancer.
Chen D; Cao L; Wang X
Oncol Rep; 2019 Aug; 42(2):679-687. PubMed ID: 31233194
[TBL] [Abstract][Full Text] [Related]
4. MPZL1 Promotes Lung Adenocarcinoma Progression by Enhancing Tumor Proliferation, Invasion, Migration, and Suppressing Immune Function via Transforming Growth Factor-β1.
Wang A; Fan F; Zang C; Li C; Hong H; Wang Z; Gao Y; Chen L; Yu X; Zhou C; Zhao C
Hum Gene Ther; 2023 Jun; 34(11-12):540-553. PubMed ID: 37183407
[TBL] [Abstract][Full Text] [Related]
5. MPZL1 is highly expressed in advanced gallbladder carcinoma and promotes the aggressive behavior of human gallbladder carcinoma GBC‑SD cells.
Liu X; Huang J; Liu L; Liu R
Mol Med Rep; 2019 Sep; 20(3):2725-2733. PubMed ID: 31322261
[TBL] [Abstract][Full Text] [Related]
6. LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway.
He Y; Jiang X; Duan L; Xiong Q; Yuan Y; Liu P; Jiang L; Shen Q; Zhao S; Yang C; Chen Y
Mol Cancer; 2021 Dec; 20(1):156. PubMed ID: 34856993
[TBL] [Abstract][Full Text] [Related]
7. Novel long non-coding RNA LBX2-AS1 indicates poor prognosis and promotes cell proliferation and metastasis through Notch signaling in non-small cell lung cancer.
Tang LX; Su SF; Wan Q; He P; Xhang Y; Cheng XM
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7419-7429. PubMed ID: 31539129
[TBL] [Abstract][Full Text] [Related]
8. PRDX2 Promotes the Proliferation and Metastasis of Non-Small Cell Lung Cancer
Chen Y; Yang S; Zhou H; Su D
Biomed Res Int; 2020; 2020():8359860. PubMed ID: 32908916
[TBL] [Abstract][Full Text] [Related]
9. Cell adhesion molecule 4 suppresses cell growth and metastasis by inhibiting the Akt signaling pathway in non-small cell lung cancer.
Luo F; Zhao Y; Liu J
Int J Biochem Cell Biol; 2020 Jun; 123():105750. PubMed ID: 32325280
[TBL] [Abstract][Full Text] [Related]
10. The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer.
Liu XH; Liu ZL; Sun M; Liu J; Wang ZX; De W
BMC Cancer; 2013 Oct; 13():464. PubMed ID: 24103700
[TBL] [Abstract][Full Text] [Related]
11. LINC00632 inhibits the malignant development of non-small cell lung cancer by downregulating miR-1203.
Luo T; Yan L; Liu H
J BUON; 2020; 25(3):1517-1524. PubMed ID: 32862599
[TBL] [Abstract][Full Text] [Related]
12. Enhanced expression of circular RNA hsa_circ_000984 promotes cells proliferation and metastasis in non-small cell lung cancer by modulating Wnt/β-catenin pathway.
Li XY; Liu YR; Zhou JH; Li W; Guo HH; Ma HP
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3366-3374. PubMed ID: 31081091
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of nucleolin is indispensable to its involvement in the proliferation and migration of non-small cell lung cancer cells.
Huang F; Wu Y; Tan H; Guo T; Zhang K; Li D; Tong Z
Oncol Rep; 2019 Jan; 41(1):590-598. PubMed ID: 30320343
[TBL] [Abstract][Full Text] [Related]
14. COL11A1 is overexpressed in recurrent non-small cell lung cancer and promotes cell proliferation, migration, invasion and drug resistance.
Shen L; Yang M; Lin Q; Zhang Z; Zhu B; Miao C
Oncol Rep; 2016 Aug; 36(2):877-85. PubMed ID: 27373316
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
Huang Y; Ni R; Wang J; Liu Y
Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
[TBL] [Abstract][Full Text] [Related]
16. STAT3-induced long noncoding RNA LINC00668 promotes migration and invasion of non-small cell lung cancer via the miR-193a/KLF7 axis.
An YX; Shang YJ; Xu ZW; Zhang QC; Wang Z; Xuan WX; Zhang XJ
Biomed Pharmacother; 2019 Aug; 116():109023. PubMed ID: 31150989
[TBL] [Abstract][Full Text] [Related]
17. Lower miR-340 expression predicts poor prognosis of non-small cell lung cancer and promotes cell proliferation by targeting CDK4.
Qin Y; Zhou X; Huang C; Li L; Liu H; Liang N; Chen Y; Ma D; Han Z; Xu X; He J; Li S
Gene; 2018 Oct; 675():278-284. PubMed ID: 29935356
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA ciRS-7 correlates with advance disease and poor prognosis, and its down-regulation inhibits cells proliferation while induces cells apoptosis in non-small cell lung cancer.
Yan B; Zhang W; Mao XW; Jiang LY
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8712-8721. PubMed ID: 30575911
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of LncRNA-HIT promotes migration and invasion of non-small cell lung cancer cells by association with ZEB1.
Jia X; Wang Z; Qiu L; Yang Y; Wang Y; Chen Z; Liu Z; Yu L
Cancer Med; 2016 Dec; 5(12):3555-3563. PubMed ID: 27790864
[TBL] [Abstract][Full Text] [Related]
20. MCRS1 overexpression, which is specifically inhibited by miR-129*, promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer.
Liu MX; Zhou KC; Cao Y
Mol Cancer; 2014 Nov; 13():245. PubMed ID: 25373388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]